BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6157996)

  • 1. An interferon-induced cellular enzyme is incorporated into virions.
    Wallach D; Revel M
    Nature; 1980 Sep; 287(5777):68-70. PubMed ID: 6157996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interferon-induced enzyme oligo-isoadenylate synthetase: rapid determination of its in vitro products.
    Merlin G; Revel M; Wallach D
    Anal Biochem; 1981 Jan; 110(1):190-6. PubMed ID: 6163372
    [No Abstract]   [Full Text] [Related]  

  • 3. A mouse cell line, which is unprotected by interferon against lytic virus infection, lacks ribonuclease F activity.
    Epstein DA; Czarniecki CW; Jacobsen H; Friedman RM; Panet A
    Eur J Biochem; 1981 Aug; 118(1):9-15. PubMed ID: 6169526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virus-specific effects of interferon in embryonal carcinoma cells.
    Nilsen TW; Wood DL; Baglioni C
    Nature; 1980 Jul; 286(5769):178-80. PubMed ID: 6157099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of TBK1 and IKKvarepsilon kinases by vesicular stomatitis virus infection and the role of viral ribonucleoprotein in the development of interferon antiviral immunity.
    tenOever BR; Sharma S; Zou W; Sun Q; Grandvaux N; Julkunen I; Hemmi H; Yamamoto M; Akira S; Yeh WC; Lin R; Hiscott J
    J Virol; 2004 Oct; 78(19):10636-49. PubMed ID: 15367631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of an antiviral state by interferon in the absence of elevated levels of 2,5-oligo(A) synthetase and eIF-2 kinase.
    Lewis JA
    Virology; 1988 Jan; 162(1):118-27. PubMed ID: 2447700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of 2'5'-oligoadenylic acid on a mouse cell line partially resistant to interferon.
    Panet A; Czarniecki CW; Falk H; Friedman RM
    Virology; 1981 Oct; 114(2):567-72. PubMed ID: 6170160
    [No Abstract]   [Full Text] [Related]  

  • 8. Interferon-induced enzymes: activation and role in te antiviral state.
    Baglioni C; Benvin S; Maroney PA; Minks MA; Nilsen TW; West DK
    Ann N Y Acad Sci; 1980; 350():497-509. PubMed ID: 6165300
    [No Abstract]   [Full Text] [Related]  

  • 9. Interferon induces the production of membrane protein-deficient and infectivity-defective vesicular stomatitis virions through interference in the virion assembly process.
    Jay FT; Dawood MR; Friedman RM
    J Gen Virol; 1983 Mar; 64 Pt 3():707-12. PubMed ID: 6186764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on interferon-sensitive cells derived from the interferon-resistant NIH 3T3 clone 1 line.
    Mittnacht S; Jacobsen H
    Prog Clin Biol Res; 1985; 202():237-45. PubMed ID: 2421304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2'5' oligo(A) polymerase activity in serum of mice infected with EMC virus or treated with interferon.
    Krishnan I; Baglioni C
    Nature; 1980 Jun; 285(5765):485-8. PubMed ID: 6157092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-dependent induction of mRNA activity for (2'-5')oligo-isoadenylate synthetase.
    Shulman L; Revel M
    Nature; 1980 Nov; 288(5786):98-100. PubMed ID: 6159548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of the stability of poly(I)xpoly(C)-induced human fibroblast interferon mRNA: selective inactivation of interferon mRNA and lack of involvement of 2',5'-oligo(A) synthetase activation during the shutoff of interferon production.
    Sehgal PB; Gupta SL
    Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3489-93. PubMed ID: 6158049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-free protein synthesis and interferon action: protein kinase(s) and an oligonucleotide effector, pppA2'p5'A2'p5'A.
    Kerr IM; Williams BR; Hovanessian AG; Brown RE; Martin EM; Gilbert CS; Birdsall NJ
    Haematol Blood Transfus; 1979; 23():291-4. PubMed ID: 94574
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of interferon on assembly of intracellular Moloney murine leukemia virus particles in chronically infected 3T3/NIH cells.
    Aboud M; Hassan Y; Huleihel M
    Arch Virol; 1982; 74(4):249-58. PubMed ID: 6187315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of vesicular stomatitis virus with low infectivity by interferon-treated cells.
    Maheshwari RK; Friedman RM
    J Gen Virol; 1979 Jul; 44(1):261-4. PubMed ID: 227998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accumulation and breakdown of RNA-deficient intracellular virus particles in interferon-treated NIH 3T3 cells chronically producing Moloney murine leukemia virus.
    Aboud M; Hassan Y
    J Virol; 1983 Feb; 45(2):489-95. PubMed ID: 6187933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetherin Inhibits Cell-Free Virus Dissemination and Retards Murine Leukemia Virus Pathogenesis.
    Liberatore RA; Mastrocola EJ; Powell C; Bieniasz PD
    J Virol; 2017 Jun; 91(12):. PubMed ID: 28381565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Casein kinase II is the P protein phosphorylating cellular kinase associated with the ribonucleoprotein complex of purified vesicular stomatitis virus.
    Gupta AK; Das T; Banerjee AK
    J Gen Virol; 1995 Feb; 76 ( Pt 2)():365-72. PubMed ID: 7844556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The target reaction in the antiviral action of mouse interferon against vesicular stomatitis virus multiplication.
    Hoshino M; Taira H; Hattori S; Kawakita M
    J Biochem; 1987 Mar; 101(3):685-94. PubMed ID: 2439495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.